Retinopathy of Prematurity-Incidence Today

Clinics in Perinatology

Volumn 40, Issue 2, 2013, Pages 185-200

  Zin, Andrea ^a   Gole, Glen A ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Childhood blindness; Retinopathy of prematurity; Retinopathy of prematurity detection; Retinopathy of prematurity incidence

Indexed keywords

BEVACIZUMAB; OXYGEN;

BIRTH WEIGHT; BLINDNESS; CLINICAL TRIAL (TOPIC); CRYOTHERAPY; DISEASE SEVERITY; EASTERN EUROPE; EPIDEMIC; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INDIA; INFANT MORTALITY; MATERNAL CARE; NEWBORN CARE; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RESUSCITATION; RETROLENTAL FIBROPLASIA; REVIEW; SOUTH AND CENTRAL AMERICA;

BLINDNESS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; NEONATAL SCREENING; PREGNANCY; RETINOPATHY OF PREMATURITY;

EID: 84878171739     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2013.02.001     Document Type: Review

References (79)

1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008, 84(2):77-82.
2. Kong L., Fry M., Al-Samarraie M., et al. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS 2012, 16(6):501-507.
3. Silverman W.A. Retrolental fibroplasia: a modern parable 1980, Grune and Stratton, Inc, New York, p. 207.
4. Kinsey V.E., Hemphill F.M. Etiology of retrolental fibroplasia and preliminary report of the Cooperative Study of Retrolental Fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 1955, 59:15-24.
5. Bolton D.P., Cross K.W. Further observations on cost of preventing retrolental fibroplasia. Lancet 1974, 1(7855):445-448.
6. Group CfRoPC Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990, 108(2):195-204.
7. CfRoPC Group Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1990, 108(10):1408-1416.
8. Good W.V., Hardy R.J., Dobson V., et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005, 116(1):15-23.
9. Palmer E.A., Flynn J.T., Hardy R.J., et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991, 98(11):1628-1640.
10. Ahmed M.A., Duncan M., Kent A., et al. Incidence of retinopathy of prematurity requiring treatment in infants born greater than 30 weeks' gestation and with a birthweight greater than 1250 g from 1998 to 2002: a regional study. J Paediatr Child Health 2006, 42(6):337-340.
11. Austeng D., Kallen K.B., Ewald U.W., et al. Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden. Arch Ophthalmol 2009, 127(10):1315-1319.
12. Charan R., Dogra M.R., Gupta A., et al. The incidence of retinopathy of prematurity in a neonatal care unit. Indian J Ophthalmol 1995, 43(3):123-126.
13. Flores-Santos R., Hernandez-Cabrera M.A., Henandez-Herrera R.J., et al. Screening for retinopathy of prematurity: results of a 7-year study of underweight newborns. Arch Med Res 2007, 38(4):440-443.
14. Gunn D.J., Cartwright D.W., Gole G.A. Incidence of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol 2012, 40(1):93-99.
15. Darlow B.A., Hutchinson J.L., Henderson-Smart D.J., et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005, 115(4):990-996.
16. Weber C., Weninger M., Klebermass K., et al. Mortality and morbidity in extremely preterm infants (22 to 26 weeks of gestation): Austria 1999-2001. Wien Klin Wochenschr 2005, 117(21-22):740-746.
17. Allegaert K. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol 2004, 88(2):239-242.
18. Shah P.S., Sankaran K., Aziz K., et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern?. J Perinatol 2012, 32(2):132-138.
19. Prpić I., Mahulja-Stamenković V., Kovacević D., et al. Prevalence of severe retinopathy of prematurity in a geographically defined population in Croatia. Coll Antropol 2011, 35(Suppl 2):69-72.
20. Schwarz E.C., Grauel E.L., Wauer R.R. Kein Anstieg von Inzidenz, Therapie- und Erblindungsrate der Retinopathia praematurorum in einem universitaren Perinatalzentrum Level 1-eine prospektive Beobachtungsstudie von 1978-2007. Klin Monbl Augenheilkd 2011, 228(3):208-219. [in German].
21. Wani V.B., Kumar N., Sabti K., et al. Results of screening for retinopathy of prematurity in a large nursery in Kuwait: incidence and risk factors. Indian J Ophthalmol 2010, 58(3):204-208.
22. Markestad T., Kaaresen P.I., Ronnestad A., et al. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005, 115(5):1289-1298.
23. Binkhathlan A.A., Almahmoud L.A., Saleh M.J., et al. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol 2008, 92(2):167-169.
24. Amer M., Jafri W.H., Nizami A.M., et al. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?. Br J Ophthalmol 2012, 96(8):1052-1055.
25. Shah V.A., Yeo C.L., Ling Y.L., et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005, 34(2):169-178.
26. Brennan R., Gnanaraj L., Cottrell D.G. Retinopathy of prematurity in practice. I: screening for threshold disease. Eye (Lond) 2003, 17(2):183-188.
27. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126(3):443-456.
28. Horbar J.D., Carpenter J.H., Badger G.J., et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012, 129(6):1019-1026.
29. Tavosnanska J. Morbimortalidad de recién nacidos con menos de 1500 gramos asistidos en hospitales públicos de la Ciudad de Buenos Aires. Arch Argent Pediatr 2012, 110(5):394-403.
30. Fortes Filho J.B., Eckert G.U., Procianoy L., et al. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond) 2009, 23(1):25-30.
31. Zin A.A., Moreira M.E., Bunce C., et al. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics 2010, 126(2):e410-e417.
32. Li Q.P., Wang Z., Li Y.Y., et al. Retinopathy of prematurity screening in 2185 premature infants. Zhonghua Yan Ke Za Zhi 2012, 48(10):903-907. [in Chinese].
33. Zuluaga C., Llanos G., Torres J. Effects of the screening program on ROP in Cali, Colombia. Acta Med Lituan 2006, 13(3):176-178.
34. Saeidi R., Hashemzadeh A., Ahmadi S., et al. Prevalence and predisposing factors of retinopathy of prematurity in very low-birth-weight infants discharged from NICU. Iran J Pediatr 2009, 19(1):59-63.
35. Jakuskiene R., Vollmer B., Saferis V., et al. Neonatal outcomes of very preterm infants admitted to a tertiary center in Lithuania between the years 2003 and 2005. Eur J Pediatr 2011, 170(10):1293-1303.
36. Vâtavu I., Nascutzy C., Ciomârtan T., et al. Retinopathy of prematurity-screening results. Oftalmologia 2010, 54(1):110-117. [in Romanian].
37. Knezević S., Stojanović N., Oros A., et al. Analysis of risk factors in the development of retinopathy of prematurity. Srp Arh Celok Lek 2011, 139(7-8):433-438. [in Serbian].
38. Delport S.D., Swanepoel J.C., Odendaal P.J., et al. Incidence of retinopathy of prematurity in very-low-birth-weight infants born at Kalafong Hospital, Pretoria. S Afr Med J 2002, 92(12):986-990.
39. Akkoyun I., Oto S., Yilmaz G., et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006, 10(5):449-453.
40. Gopal L., Sharma T., Ramachandran S., et al. Retinopathy of prematurity: a study. Indian J Ophthalmol 1995, 43(2):59-61.
41. Varughese S., Jain S., Gupta N., et al. Magnitude of the problem of retinopathy of prematurity. Experience in a large maternity unit with a medium size level-3 nursery. Indian J Ophthalmol 2001, 49(3):187-188.
42. Vinekar A., Dogra M.R., Sangtam T., et al. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: ten year data from a tertiary care center in a developing country. Indian J Ophthalmol 2007, 55(5):331-336.
43. Jalali S., Matalia J., Hussain A., et al. Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries. Am J Ophthalmol 2006, 141(5):966-968.
44. Hungi B., Vinekar A., Datti N., et al. Retinopathy of prematurity in a rural neonatal intensive care unit in South India-a prospective study. Indian J Pediatr 2012, 79(7):911-915.
45. Taqui A.M., Syed R., Chaudhry T.A., et al. Retinopathy of prematurity: frequency and risk factors in a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 2008, 58(4):186-190.
46. Phan M.H., Nguyen P.N., Reynolds J.D. Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. J Pediatr Ophthalmol Strabismus 2003, 40(4):208-212.
47. Ahmed A.S., Muslima H., Anwar K.S., et al. Retinopathy of prematurity in Bangladeshi neonates. J Trop Pediatr 2008, 54(5):333-339.
48. International Committee for the Classification of Retinopathy of Prematurity The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005, 123(7):991-999.
49. Mintz-Hittner H.A., Kennedy K.A., Chuang A.Z., BEAT-ROP Cooperative Group Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011, 364(7):603-615.
50. Gilbert C., Fielder A., Gordillo L., et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005, 115(5):e518-e525.
51. Patwardhan S.D., Azad R., Gogia V., et al. Prevailing clinical practices regarding screening for retinopathy of prematurity among pediatricians in India: a pilot survey. Indian J Ophthalmol 2011, 59(6):427-430.
52. Sanghi G., Dogra M.R., Katoch D., et al. Demographic profile of infants with stage 5 retinopathy of prematurity in North India: implications for screening. Ophthalmic Epidemiol 2011, 18(2):72-74.
53. Shah P.K., Narendran V., Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed 2012, 97(5):F371-F375.
54. Stahl A., Connor K.M., Sapieha P., et al. The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 2010, 51(6):2813-2826.
55. Sanghi G., Dogra M.R., Dogra M., et al. A hybrid form of retinopathy of prematurity. Br J Ophthalmol 2012, 96(4):519-522.
56. Blencowe H., Cousens S., Oestergaard M.Z., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379(9832):2162-2172.
57. Lopez J.H., Perry G. Inequality in Latin America: determinants and consequences 2008, The World Bank, Washington, DC.
58. Gilbert C., Rahi J., Eckstein M., et al. Retinopathy of prematurity in middle-income countries. Lancet 1997, 350:12-14.
59. Zepeda Romero L.C., Gutierrez Padilla J.A., De la Fuente-Torres M.A., et al. Detection and treatment for retinopathy of prematurity in Mexico: need for effective programs. J AAPOS 2008, 12(3):225-226.
60. Zepeda-Romero L.C., Barrera-de-Leon J.C., Camacho-Choza C., et al. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol 2011, 95(11):1502-1505.
61. Zuluaga C., Sierra M.V., Asprilla E. Causas de ceguera infantil en Cali, Colombia. Colomb Med 2005, 36:235.
62. Lomuto C.C., Galina L., Brussa M., et al. Epidemiologia de la retinopatia del prematuro en servicios publicos de la Argentina durante 2008. Arch Argent Pediatr 2010, 108(1):24-30. [in Spanish].
63. Turkowsky J.D., Cervantes A.C., Rocha P.V., et al. Incidence of retinopathy of prematurity (ROP) and its evolution in the population preterms of very low birth weight survivors and that was discharged from the Instituto Especializado Materno Perinatal of Lima. Rev Peru Pediatr 2007, 60(2):88-92. [in Spanish].
64. Restrepo M.M., Guzman A.H., Gomez J.H., et al. Epidemiología de la retinopatía del prematuroen Medellín, 2003-2008. Iatreia 2011, 24(3):25-258. [in Spanish].
65. Fernández Y.G., Ragi R.M., Rivero M.R., et al. Incidencia de la retinopatía de la prematuridad. Rev Cubana Pediatr 2007, 79(2):1-6. [in Spanish].
66. Fortes Filho J.B., Eckert G.U., Valiatti F.B., et al. Prevalence of retinopathy of prematurity: an institutional cross-sectional study of preterm infants in Brazil. Rev Panam Salud Publica 2009, 26(3):216-220.
67. Chen Y., Li X. Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic?. Br J Ophthalmol 2006, 90(3):268-271.
68. Filho J.B., Barros C.K., da Costa M.C., et al. Results of a program for the prevention of blindness caused by retinopathy of prematurity in southern Brazil. J Pediatr (Rio J) 2007, 83(3):209-216.
69. Bamashmus M.A., Al-Akily S.A. Profile of childhood blindness and low vision in Yemen: a hospital-based study. East Mediterr Health J 2010, 16(4):425-428.
70. Available at: Accessed March 23, 2013. http://HDR_2011_EN_Table3.pdf.
71. Furtado J.M., Lansingh V.C., Carter M.J., et al. Causes of blindness and visual impairment in Latin America. Surv Ophthalmol 2012, 57(2):149-177.
72. Crofts B.J., King R., Johnson A. The contribution of low birth weight to severe vision loss in a geographically defined population. Br J Ophthalmol 1998, 82(1):9-13.
73. O'Connor A.R., Wilson C.M., Fielder A.R. Ophthalmological problems associated with preterm birth. Eye (Lond) 2007, 21(10):1254-1260.
74. March of Dimes P, Save the Children, WHO. Born too soon: the global action report on preterm birth 2012, World Health Organisation, Geneva (Switzerland). C.P. Howson, M.V. Kinney, J.E. Lawn (Eds.).
75. Dandona R., Dandona L. Childhood blindness in India: a population based perspective. Br J Ophthalmol 2003, 87(3):263-265.
76. Nations U. The Millennium Development Goals report 2012 2012, United Nations, New York.
77. Victora C.G., Aquino E.M., do Carmo Leal M., et al. Maternal and child health in Brazil: progress and challenges. Lancet 2011, 377(9780):1863-1876.
78. Barros F.C., Victora C.G., Barros A.J., et al. The challenge of reducing neonatal mortality in middle-income countries: findings from three Brazilian birth cohorts in 1982, 1993, and 2004. Lancet 2005, 365(9462):847-854.
79. Chang H.H., Larson J., Blencowe H., et al. Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 2013, 381:223-234.